scholarly journals n-3 Polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: a case–control study in Korea

2008 ◽  
Vol 100 (03) ◽  
pp. 609-614 ◽  
Author(s):  
Eunjeong Lee ◽  
Sangyeoup Lee ◽  
Yongsoon Park
Keyword(s):  
Metabolic Syndrome ◽  
Fatty Acids ◽  
Polyunsaturated Fatty Acids ◽  
Trans Fatty Acids ◽  
Case Control Study ◽  
Case Control ◽  
The Metabolic Syndrome ◽  
Control Study

scholarly journals Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study

2011 ◽  
Vol 164 (3) ◽  
pp. 381-388 ◽  
Author(s):  
Chloe Y Y Cheung ◽  
Annette W K Tso ◽  
Bernard M Y Cheung ◽  
Aimin Xu ◽  
K L Ong ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Genetic Risk ◽  
Chinese Population ◽  
Central Obesity ◽  
Case Control Study ◽  
Case Control ◽  
Cross Sectional ◽  
The Metabolic Syndrome ◽  
Control Study

ObjectiveCentral obesity predisposes to various cardiometabolic diseases and is a key component of the metabolic syndrome (MetS). We have previously demonstrated that three obesity-susceptible single nucleotide polymorphisms (SNPs), rs10938397 (GNPDA2), rs8050136 (FTO) and rs17782313 (MC4R), were associated with obesity and waist circumference in cross-sectional studies in the Chinese population. In this study, we investigate whether these SNPs could also predict the persistence of central obesity and MetS in subjects from the Hong Kong Cardiovascular Risk Factors Prevalence Study (CRISPS) cohort.Design and methodsWe genotyped these SNPs in i) 354 subjects with and 994 subjects without central obesity at both baseline and a 12-year follow-up, ii) 2214 subjects (816 cases and 1398 controls) in an MetS cross-sectional case–control study and iii) 225 subjects with and 1221 subjects without MetS at both baseline and the 12-year follow-up.ResultsBoth FTO rs8050136 (Page, sex-adjusted=0.019; odds ratio (OR) (95% confidence intervals (CI)): 1.35 (1.05, 1.73)) and GNPDA2 rs10938397 (Page, sex-adjusted=3×10−3; OR (95% CI): 1.34 (1.11, 1.63)) were significantly associated with persistent central obesity. GNPDA2 rs10938397 was also significantly associated with MetS (Page, sex-adjusted=0.011, OR (95% CI): 1.20 (1.04, 1.38)) in the case–control study. However, none of these SNPs showed an individual association with persistent MetS. In the combined genetic risk analyses for persistent central obesity and persistent MetS, the combined genetic risk score of the three SNPs showed an OR of 1.25 (95% CI: 1.10, 1.42; Page, sex-adjusted=4.92×10−3) and 1.19 (95% CI: 1.03, 1.38; Page, sex-adjusted=0.019) for each additional risk allele respectively.ConclusionThis study demonstrated that FTO and GNPDA2 variants predicted persistent central obesity in the Chinese population, further supporting their importance as obesity-susceptible genes.

scholarly journals Metabolic Syndrome Components and Acute pancreatitis: A Case-Control Study in China

2020 ◽  
Author(s):  
zhemin Shen ◽  
Xueqiao Wang ◽  
Zili Zhen ◽  
Yao Wang ◽  
Peilong Sun
Keyword(s):  
Metabolic Syndrome ◽  
Acute Pancreatitis ◽  
Incidence Rate ◽  
Case Control Study ◽  
Case Control ◽  
Control Group ◽  
Inflammatory Disorder ◽  
The Metabolic Syndrome ◽  
Metabolic Syndrome Components ◽  
Control Study

Abstract Background: Acute pancreatitis (AP) is a common inflammatory disorder of pancreas. Recent evidence has shown that metabolic syndrome was positively correlated with the severity of AP. However, only few studies have revealed the relationship between metabolic syndrome and the occurrence of AP. We therefore elucidated the association between the metabolic syndrome components and the incidence rate of AP. Methods: A hospital-based case-control study was conducted. 705 patients admitted to our hospital from January 2016 to December 2018 were included in the study. Subjects were divided into case and control group according to their diagnosis: (1) According to the revised Atlanta classification from 2012, patients diagnosed as AP were enrolled into case group. (2) Patients without history of AP or any disease related to metabolic syndrome were allocated into control group. Controls were matched to cases individually by sex and age (control/case ratio=1). Risk factors were determined by univariate and multivariate logistic regression analyses. Results: The incidence rate of metabolic syndrome with AP patients was 30.9%, which was more frequent than controls (13.2%) (OR=2.975; 95%CI 1.947-4.548, p<0.001). In multivariate regression analysis, histories of smoking or alcohol drinking, biliary stone were important predictors of AP. Besides, occurrence of AP was significantly associated with total cholesterol (TC) (OR=1.831; 95%CI 1.137-2.948, p=0.013), triglyceride (TG) (OR=2.058; 95%CI 1.332-3.179, p=0.001), fasting plasma glucose (FPG) (OR =2.345; 95%CI 1.395-3.940, p=0.001), as well as low values of apolipoprotein A (Apo A) (OR =0.247; 95%CI 0.146-0.416, p<0.001). Conclusion: Metabolic syndrome and its components portend high risks of occurrence of AP.

scholarly journals Case–Control Study of the Metabolic Syndrome and Metabolic Risk Factors for Endometrial Cancer

2011 ◽  
Vol 20 (11) ◽  
pp. 2384-2395 ◽  
Author(s):  
Christine M. Friedenreich ◽  
Rita K. Biel ◽  
David C.W. Lau ◽  
Ilona Csizmadi ◽  
Kerry S. Courneya ◽  
...  
Keyword(s):  
Risk Factors ◽  
Metabolic Syndrome ◽  
Endometrial Cancer ◽  
Case Control Study ◽  
Case Control ◽  
Metabolic Risk Factors ◽  
Metabolic Risk ◽  
The Metabolic Syndrome ◽  
Control Study

scholarly journals Serum Fatty Acids and Risk of Cutaneous Melanoma: A Population-Based Case-Control Study

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Marco Vinceti ◽  
Carlotta Malagoli ◽  
Laura Iacuzio ◽  
Catherine M. Crespi ◽  
Sabina Sieri ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Linoleic Acid ◽  
Polyunsaturated Fatty Acids ◽  
Cutaneous Melanoma ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Melanoma Risk ◽  
Percentage Composition ◽  
Control Study

Background. Some observational studies have suggested that excess dietary intake of polyunsaturated fatty acids such as linoleic acid increases cutaneous melanoma risk. We aimed at examining the association between serum fatty acids and melanoma risk by conducting a population-based case-control study in a northern Italy community.Methods. The percentage composition of 12 fatty acids was determined in 51 newly diagnosed melanoma patients and 51 age- and sex-matched population controls by extracting total lipids from serum samples using thin layer and gas chromatography. Conditional logistic regression was used to estimate the relative risk of melanoma associated with tertiles of percentage composition of each fatty acid as well as groupings including saturated, monounsaturated, and polyunsaturated fatty acids.Results. We found a slightly increased melanoma risk for stearic and arachidic acids proportion, with and without adjustment for potential confounders. For an n-3 polyunsaturated fatty acid, docosapentaenoic acid, we found a male-specific direct association with melanoma risk. No other associations emerged for the other saturated, monounsaturated, and polyunsaturated fatty acids, individually or grouped by type.Conclusions. These findings do not suggest a major role of fatty acids, including linoleic acid, on risk of cutaneous melanoma, though their evaluation is limited by the small sample size.

scholarly journals Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: An endoscopy-based case-control study

2008 ◽  
Vol 123 (8) ◽  
pp. 1974-1977 ◽  
Author(s):  
Gerda K. Pot ◽  
Anouk Geelen ◽  
Else-Mariëtte B. van Heijningen ◽  
Christine L.E. Siezen ◽  
Henk J. van Kranen ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Polyunsaturated Fatty Acids ◽  
Colorectal Adenoma ◽  
Case Control Study ◽  
Case Control ◽  
Adenoma Risk ◽  
Control Study

scholarly journals Modified metabolic syndrome and second cancers in women: A case control study

2016 ◽  
Vol 05 (04) ◽  
pp. 189-191
Author(s):  
Carlos-Manuel Ortiz-Mendoza ◽  
Ernesto Pérez-Chávez ◽  
Tania-Angélica De-la Fuente-Vera
Keyword(s):  
Diabetes Mellitus ◽  
Metabolic Syndrome ◽  
Case Control Study ◽  
Serum Levels ◽  
Case Control ◽  
Fasting Serum ◽  
Second Cancers ◽  
The Metabolic Syndrome ◽  
Anthropometric Features ◽  
Control Study

Abstract Background: According to some studies, the metabolic syndrome causes diverse primary cancers; however, there is no evidence about metabolic syndrome impact on second cancers development in women. Aim: To find out the implication of the modified metabolic syndrome in women with second cancers. Materials and Methods: This was a case-control study, at a general hospital in Mexico City, in women with second cancers (cases) and age-matched women with only one neoplasm (controls). The analysis comprised: Tumor (s), anthropometric features, and body mass index (BMI); moreover, presence of diabetes mellitus, hypertension, and fasting serum levels of total cholesterol, triglycerides and glucose. Results: The sample was of nine cases and 27 controls. In cases, the metabolic syndrome (diabetes mellitus or glucose > 99 mg/dL + hypertension or blood pressure ≥ 135/85 mm Hg + triglycerides > 149 mg/dL or BMI ≥ 30 kg/m 2 ) was more frequent (odds ratio 20.8, 95% confidence interval: 1.9-227.1). Conclusion: Our results suggest that in women, the modified metabolic syndrome may be a risk factor for second cancers.

Sign in / Sign up

Export Citation Format

Share Document